When Jan Garfinkle couldn't get a job at a Michigan venture capital firm, she started her own.

Garfinkle, who grew up in San Francisco, had more than a decade of experience working with startups before moving to Michigan in the early 1990s.

But the venture capital community in the state was exceedingly small at that time, and none of them were hiring.

"I thought, this is crazy," Garfinkle said. "I'm going to start my own venture fund."

Garfinkle's goal was to change health care by starting a venture capital firm that could help with rising health care costs, which were 12 percent of the GDP at that point.

With that mission in mind, Garfinkle founded Arboretum Ventures with Timothy Petersen in 2002 to focus on emerging health care companies in the Midwest.

"I felt that through innovation, we should be able to provide better health care at a lower cost point," Garfinkle said. "The founding principle of Arboretum is investing in companies that will drive costs out of our health care system but still provide great clinical care."

Today, Ann Arbor-based Arboretum Ventures has 15 employees and manages $700 million in five funds. The venture capital firm has invested in 55 portfolio companies, which employ 4,000 people.

Arboretum Ventures has been incredibly successful. Last year, the firm raised the largest VC fund in state history, closing Arboretum Ventures V LP at $250 million.

"I was an odd duck coming to Michigan, and to be able to have done what we did is such a blessing for me," Garfinkle said. "I'm so proud of the Arboretum team and what we've accomplished."

How did health care become a focus for you?

I wanted to be a pediatrician when I was growing up, but careers are winding paths. I went to school at Berkeley in the College of Engineering. I studied bioengineering because it's a combination of engineering and pre-med. When I started my career, I was trying to get a job in bioengineering, but it was hard back then. It had just become a new major and there were few jobs. My first job was in manufacturing working for Procter & Gamble making Pampers diapers. I did that for three years and then wanted to get into medical devices. For some reason, I just happened to love them. I have no idea why. My parents are not in the health field. I decided to go to business school at Wharton and had an incredible internship as a marketing analyst at Eli Lilly (an American pharmaceutical company headquartered in Indianapolis, Ind.). They were trying to acquire medical device companies at that time. I worked with a physician who started Advanced Cardiovascular Systems, a venture-backed angioplasty company. Back in the early 1980s, if a patient was having a heart attack, you'd either give them a nitroglycerin pill to relax their arteries and treat their blockage, or they'd have to have a bypass procedure, which is a huge surgical procedure. With the advent of angioplasty, an image could be taken of the coronary arteries to see the blockage. Then, a tiny balloon is inserted across the blockage through a small hole in one of your arteries. It's noninvasive an easy way to stop a patient's heart attack. Patients only had to stay in the hospital for a day and then were able to go home. It changed the world of cardiology and health care for cardiac patients.

What was your experience like when you first worked with a startup?

After I received my MBA, I got a job at ACS working in marketing and sales. I had a great experience launching 20 different medical technologies while I was there. The physician who started ACS asked me if I would write the business plan for his second company, Devices for Vascular Intervention. I wrote the plan and then joined that company. At DVI, I was director of Marketing and director of Clinical Research, where I led the big FDA trial to get FDA approval for an atherectomy catheter, and then launched it worldwide to all the physicians that were doing angioplasties. I had incredible operating experiences in both of those companies. I fell in love with the entrepreneurial spirit of these new medical technologies that were changing the world for patients and making a much better life for them.

California is known for its venture capital ecosystem. Why did you move to Michigan?

My husband moved from Chicago to California when we got married. We met in California, where he was in training as a cardiologist. However, after a couple years in California, he said, 'I'm really not that happy here.' He found a job in Michigan, and I was a reluctant trailing spouse at that point. We had three little girls around that time. It was just a really, really busy time. I couldn't see how I could do everything, so I quit my job. However, Guidant (a spin-off company of Eli Lilly) called me and said, 'Would you do some consulting for us?' I said, 'I'd love to do about 10 hours a week.' That led me to start a consulting business, with Guidant as my main client. Around that time, the state of Michigan created the Michigan Life Sciences Corridor, where they invested tobacco settlement dollars into startups in the health care space. Every six months or so I helped one new startup with their business plan. I also helped a few venture funds doing health care investing do some due diligence (on companies to invest in). Through those experiences, I thought I'd love working in venture. I tried to get a job at both of the venture funds that were here at the time, but neither of them were hiring. I was frustrated that I couldn't get a job in either of them. So, I went on irs.gov, filed for a tax ID number and started Arboretum Ventures in 2002.

How did you get Arboretum Ventures off the ground?

It's really hard to start a venture fund. I was so naive honestly. I didn't know what to do. Tom Porter (a Michigan venture pioneer) was a terrific mentor to me in my early days. He told me, 'Jan, you have to get a partner. No investor is going to invest in a single person venture fund.' I put out an ad in Venture Wire, which was an electronic newspaper in the early days of the internet. All these people from California that had Ph.D.s in biochemistry responded and said they knew how to run a venture fund, but they had no idea. Luckily, I met Tim Petersen, who ran the Wolverine Venture Fund at the University of Michigan. He heard I was looking for a partner and joined me about six months after I started Arboretum. We were these two very different people, but were able to come together. He knew how to run a venture fund, and I knew a lot about health care.

How did you raise your first fund?

Around this time, Mike Finney, who led the Michigan Economic Development Corp., believed we needed more venture funds in the state. He found a little pool of money, $500,000, and ran a request for proposal process. We replied to the RFP process with our proposal to start Arboretum Ventures. There were 17 applicants and two winners. We were one of them. Each fund won $250,000. However, they wouldn't give us the money up front until we closed on our first $5 million. Tim and I drove all over the upper Midwest in order to raise the money, even sleeping on the floor of my brother's house. We got so many nos when we were fundraising. We went to donors Tim knew, which were large family offices and three Michigan foundations. We also had two corporations, Guidant and a medical device corporation. These were people that could vouch for and validate what we could do because they knew us well. We were able to raise the $5 million and got the $250,000. The first close on Arboretum was $6 million. It was small, but it got us in business. The first fund actually ended up being a $25 million fund. In the early days, it's a ton of sweat equity to make it work. I went without a salary for four years. We had five employees, rent, insurance and legal bills. Our total operating budget was around $400,000. But if you persevere, you can do it. Looking back at that fund now, it is a top decile performing fund in the world of all venture funds from the 2002 vintage year.

How has the COVID-19 pandemic affected venture funding?

The deal flow in the number of companies coming to us is phenomenal. Many companies are still fundraising and new ideas are coming out. We have three companies in term sheet right now. Luckily, we met the CEOs and the management team members before COVID started. However, for the first 3-4 months of COVID we were totally focused on making sure our portfolio companies were going to be successful and survive. That was a pretty scary time for all of our portfolio companies, just like for every small business. In August, we started looking hard again at new potential companies for investment. It's been remarkable to see how companies can cut costs and still advance a technology or a clinical trial. Entrepreneurial people tend to be very resilient and tend to persevere.

Have you seen any groundbreaking technologies in health care? Anything COVID-related?

There's some cool stuff happening in cancer detection and the new drugs that are being established for cancer. There's a company in Michigan we've invested in called Strata Oncology. Strata can take a small biopsy of a cancerous tumor and determine what happened genetically to cause that tumor. It's identifying the mutation, giving the patient the drug that kills that mutation, and killing the tumor. That's going to greatly enhance the mortality and longevity of patients that get cancer. We just had a large exit with a company that was in Ann Arbor called NeuMoDx. It developed the fastest, most accurate PCR test for COVID. It's a robot that can basically take your sample and give you an accurate testing result in 80 minutes. In early March they got FDA and EUA approval. It's probably the best PCR test on the market, and they're selling millions of these tests all over the world.

How can a company that's hoping to be backed by your venture capital firm stand out?

We're trying to find the best technology in a big market with an absolutely fantastic management team. We look at all their patents, FDA and reimbursement approval. We also look at how they're going to manufacture and make money at it. There's a lot of things we have to understand and evaluate. About 2,000 companies approach us every year. We invest in two or three. It's a steep funnel to get through to the very end. Many times we'll pass on a company but say, 'come back to us when you have your first human clinical data,' as an example. A company stands out by following up in a timely manner and sharing data with us as it becomes available. It's a red flag if someone's not transparent with us about something. If they're not that's a quick no. We have to build trust.

Do you have any advice for young people considering a career in venture capital?

It's helpful to have a strong operating career to be successful in venture. That means you've worked in a company and helped launch a product to market. I encourage young people to work in as many jobs as possible at a startup. It's important to learn how to sell because you're always having to sell either yourself or your product. Finally, learn to advocate for yourself. Stuff happens all the time. Figure out how to overcome those speed bumps and don't take no for an answer. Being super resilient is one of the most important things anybody can learn.

More here:
Jan Garfinkle's path to running one of the largest VC funds in Michigan - Crain's Detroit Business

Researchers use an enhanced technique to pattern unaltered cells within a 3D hydrogel, allowing them to recreate complex biological tissue for regenerative medicine.

Image credit: Dr. Manuel Gonzlez Reyes on Pixabay

The dream for regenerative medicine is to one day repair broken bones and tissue by simply growing a replacement using a patients own cells. To date, significant strides have been made in this field, but what a research team from the University of Pennsylvania have pointed out is that current replacement tissues are simplified models at best. In some cases, this is sufficient, but regenerated tissues or grafts generally fare better and last longer when their ability to mimic actual tissue is enhanced.

In a study recently published in Advanced Materials, the team, led by Professor Robert Mauck, director of the McKay Lab and a professor of orthopaedic surgery and bioengineering, developed a new way to rebuild complex biological tissues using a modified technique that allows them to deliberately place unaltered cells within a 3D hydrogel scaffold.

We found that we were able to arrange objects, such as cells, in ways that could generate new, complex tissues without having to alter the cells themselves, said the studys first author, Hannah Zlotnick, a graduate student in bioengineering who works in the McKay Orthopaedic Research Laboratory at Penn Medicine. Others have had to add magnetic particles to the cells so that they respond to a magnetic field, but that approach can have unwanted long-term effects on cell health. Instead, we manipulated the magnetic character of the environment surrounding the cells, allowing us to arrange the objects with magnets.

As proof-of-concept, the team looked at cartilage regeneration as a viable application of this new strategy as cartilage degeneration is a common occurrence that can lead to joint instability and chronic pain. Given the complexity of cartilage tissue, few treatments exist that have lasting effects. Current fixes are to fill those holes in with synthetic or biologic materials, which can work but often wear away because they are not the same exact material as what was there before, stated the authors in a statement. Its similar to fixing a pothole in a road by filling it with gravel and making a tar patch: the hole will be smoothed out but eventually wear away with use because its not the same material and cant bond the same way.

The complexity of cartilage tissue is what makes repairing it so challenging. There is a natural gradient from the top of cartilage to the bottom, where it contacts the bone, Zlotnick explained. Superficially, or at the surface, cartilage has a high cellularity, meaning there is a higher number of cells. But where cartilage attaches to the bone, deeper inside, its cellularity is low.

Zlotnick and her collaborators used a modified technique called magnetic patterning to create their cartilage mimics. While cells are already weakly diamagnetic (i.e., will respond to an applied magnetic field), usually these approaches require them to be magnetically tagged so that their position within the gel can be better manipulated. However, this can alter their properties and the treatments longevity. Ideally, objects should be magnetically manipulated without altering their intrinsic magnetic character, according to the authors.

Rather than magnetizing the cells, the team instead enhanced the magnetic susceptibility of the cellcontaining hydrogel and their position fixed afterward. The team showed successfully that the addition of a gadoliniumbased magnetic contrast agent to a hydrogel precursor allowed a variety of diamagnetic objects, such as cells, drug delivery agents, and polystyrene beads, to be patterned in response to a magnetic field. The objects can then be easily locked in place by exposing the hydrogel to UV light, which triggers a polymerization reaction called photo crosslinking, and then washing away the magnetic solution.

These magneto-patterned engineered tissues better resemble the native tissue, in terms of their cell disposition and mechanical properties, compared to standard uniform synthetic materials or biologics that have been produced, said Mauck. By locking cells and other drug delivering agents in place via magneto-patterning, we are able to start tissues on the appropriate trajectory to produce better implants for cartilage repair.

While there are still some hurdles to overcome before these materials can be used in a clinical setting, its an important step forward for the field of regenerative medicine.

This new approach can be used to generate living tissues for implantation to fix localized cartilage defects, and may one day be extended to generate living joint surfaces, Mauck explained.

Reference: Hannah M. Zlotnick, et al. MagnetoDriven Gradients of Diamagnetic Objects for Engineering Complex Tissues, Advanced Materials (2020). DOI: 10.1002/adma.202005030

Quotes adapted from University of Pennsylvania press release

See the original post:
Growing new cartilage with magnetic fields and hydrogels - Advanced Science News

The United Nations Intergovernmental Science-Policy Platform on Biodiversity and Ecosystem Services recently published a worldwide report demonstrating that the natural world is declining globally at rates unprecedented in human history. The report shows that 75% of all ice-free land has been significantly altered by human activity, and almost 90% of global wetlands have been lost. Worse, more than two thirds of populations of mammals, birds, fish, amphibians, and reptiles have become threatened in the last 50 years.

However, the report also says that well planned conservation efforts can protect habitat and ecosystems. Signs of conservation efforts making a difference are scattered across the Vermont landscape. One example lies on the shores of Lake Bomoseen. Thanks to community members, town officials, and state agencies including the Vermont Department of Environmental Conservation and the Vermont Agency of Transportation, lake restoration projects on Lake Bomoseen in Castleton and Lake Raponda in Wilmington stabilized eroding shorelands and improved wildlife habitat.

As it turns out, what is good for water quality and wildlife is also good for humans. By protecting the natural world right at home, along Lake Bomoseen and Lake Raponda, the world just became a little healthier for all.

The projects relied on bioengineering techniques to protect the shorelands. Bioengineering is a shoreline stabilization approach that uses living plant materials as structural components to offer immediate soil protection and reinforcement, create resistance to sliding or shear displacement. Today, if you drive along Cedar Mountain Road which borders Lake Bomoseen or drive just south of the public access to Lake Raponda on Lake Raponda Road, you can see how bioengineering positively impacts ecosystems, water quality, and critical infrastructure like roads. Using biodegradable products, native plants, and natural materials, a living shoreland was re-established along the shorelines of Bomoseen and Raponda. The shorelines had been previously cleared of native vegetation and fallen prey to heightened erosion. Indeed, the loss of vegetation along the lake shore combined with development pressures associated with the presence of a road created instability and active erosion along these shoreline locations.

To address this issue, bioengineering projects were installed along the shorelines of areas that had been impacted by the installation of roads near the shoreline. The new plantings will stabilize the bank, filter water, provide habitat for wildlife, and bring some shade to all Town Beach users.

Amy Picotte is the Lakeshore Manager for the Vermont Department of Environmental Conservation. Oliver Pierson is the Lakes and Ponds Program Manager for the Vermont Department of Environmental Conservation.

See the original post:
Science in Vermont: Restore the shore | Local News - Rutland Herald

Global Coronavirus pandemic has impacted all industries across the globe, L Citrulline market being no exception. As Global economy heads towards major recession post 2009 crisis, Cognitive Market Research has published a recent study which meticulously studies impact of this crisis on Global L Citrulline market and suggests possible measures to curtail them. This press release is a snapshot of research study and further information can be gathered by accessing complete report. To Contact Research Advisor Mail us @ [emailprotected] or call us on +1-312-376-8303.

The global L Citrulline market research report is anticipated to rise at a considerable rate during forecast period, between 2020 and 2027. The global L Citrulline market report study provides intelligence studies ensuring relevant and fact-based research which help clients understand the significance and impact of market dynamics. This research report covers the current status and future prospects for the global L Citrulline market. Report offers the detailed L Citrulline market overview, development, and segment by type, application and region. In addition, L Citrulline market research report introduces the market competition overview among the major companies and companies profiles.

Global L Citrulline Market: Product analysis: Food Grade L Citrulline, Pharma Grade L Citrulline, Cosmestic Grade L Citrulline

Global L Citrulline Market: Application analysis: Food & Beverages, Cosmestics, Pharmaceuticals, Agriculture/Animal Feeds, Other

Some of the key players operating in this market include Nutra Green Biotechnology, Kyowa, Wuhan Soleado Technology, Zhaoqing City Dingkang Pharmaceutical, Ansun Bioengineering, Shanghai Join Ray Biotechnology, MH2 Biochemical, Premium Ingredient, Ningbo Yore Chemipharma . Manufacturers are facing continued downward pressure on demand, production and revenues as the COVID-19 pandemic strengthens. Manufacturing in the Euro-area experienced a substantial deterioration in its business cycle as the impact of COVID-19 hit both the demand and supply sides of the technology industry.

Get A Free Sample of L Citrulline Market Report: https://www.cognitivemarketresearch.com/chemical-%26-materials/l-citrulline-market-report#download_report

The business is particularly defenseless given that the greater part of its workforce is utilized on location employments that are impossible remotely. Also, given the idea of the business, manufacturers should be creating social distancing in workplaces that are typically worker-dense (e.g., manufacturing plants, warehouses, material movements and logistics, etc.). Furthermore, manufacturers should be prepared for major supply chain disruptions. This will influence the OEMs, however will likewise wave all through flexibly chain, influencing manufactures by driving reduced demand for materials and parts.

There is hardly any place in the world that has remained unaffected by the brutality of the Covid-19 pandemic; almost every manufacturing company is suffering from ruthless Novel Coronavirus Disease. To encompass the pandemic, many nations and Governments around the world has imposed a lockdown, restricting the gatherings and the movement of people. Lockdown has multiple consequences, which further stretch the troubles for various sector like reverse migration, disruption of supply chains, manufacturing sector. As the government have close down shops, stores and malls that helps to slow the spread of the virus, which is the major factor that is affecting the industry.

The global L Citrulline market research report examined on the basis of the various parameters such as Porters Five Force Model, SWOT Analysis which provides the precise information about the global L Citrulline market. Furthermore, in-depth analysis of the global L Citrullinemarket research report helps to identify the drivers, restraints, and opportunity regarding current market scenario.This report offers the detailed information regarding the global L Citrulline market. Report covers the brief summary of product, which defines the scope of the report in the L Citrulline market. Along with that, production methods used in it are also covered in the report. In addition, global L Citrulline market research report analyzes the diverse dynamics which are influencing the global L Citrulline market.

Any query? Enquire Here For Discount (COVID-19 Impact Analysis Updated Sample): Click Here>Download Sample Report of L Citrulline Market Report 2020 (Coronavirus Impact Analysis on L Citrulline Market)

Market Segmentation, by regions:The analysis and forecast of the global L Citrulline market research report is based on the regional basis. The report is emphasizes on the major regions. These various regions consists the detailed information regarding current trends and forecast analysis which could help the global L Citrulline market in the long period.North America (U.S., Canada, Mexico)South America (Cuba, Brazil, Argentina, and many others.)Europe (Germany, U.K., France, Italy, Russia, Spain, etc.)Asia (China, India, Russia, and many other Asian nations.)Pacific region(Indonesia, Japan, and many other Pacific nations.)Middle East & Africa (Saudi Arabia, South Africa, and many others.)

About Us:Cognitive Market Research is one of the finest and most efficient Market Research and Consulting firm. The company strives to provide research studies which include syndicate research, customized research, round the clock assistance service, monthly subscription services, and consulting services to our clients. We focus on making sure that based on our reports, our clients are enabled to make most vital business decisions in easiest and yet effective way. Hence, we are committed to delivering them outcomes from market intelligence studies which are based on relevant and fact-based research across the global market.Contact Us: +1-312-376-8303Email: [emailprotected]Web: https://www.cognitivemarketresearch.com/

The rest is here:
Global and Asia Pacific L Citrulline Market to Witness Huge Growth by 2027 Best Companies included in report Nutra Green Biotechnology, Kyowa, Wuhan...

Now in its fourth generation, the 2020 Ducati Multistrada V4 has entered the production line at Ducatis works in Borgo Panigale, Italy and is scheduled for its public unveiling this November fourth. Aside from the use of the Desmosedici Stradale V-four engine, also seen in the Panigale V4 and Streetfighter V4, the Multistrada V4 will be the first production motorcycle to use front and rear radar.

The radar system, developed in conjunction with the Department of Electronics, Information and Bioengineering of the Politecnico di Milano University, is part of Ducatis Advanced Rider Assistance Systems (ARAS) that enhances rider safety. The system features front- and rear-facing radars and each has a weight of 190 grammes, measuring 70 x 60 x 20 mm, or about the size of a box of cigarettes.

The front radar is linked to the Multistrada V4s Adaptive Cruise Control (ACC) and controls braking and acceleration to automatically adjust distance to the vehicle in front. Available with four preset distances, the system is operable between 30 to 160 km/h.

Based on systems currently used in four-wheeled vehicles, the ACC system has been modified to suit the requirements of motorcycles, notably in terms of acceleration and deceleration. These parameters are limited to ensure the rider can maintain constant control of the Multistrada V4 in any situation.

For the rear of the Multistrada V4, the rear radar monitors the bikes blind spot, notably to the rear and the outside viewing angles of the rear-view mirrors. The system already the rider to the presence of vehicles in the blind spot as well as vehicles approaching from behind at high speed.

Go here to read the rest:
2020 Ducati Multistrada V4 to come with front and rear radar - public presentation on November fourth - Paul Tan's Automotive News

Global Wearable Physical Capacity Evaluation System market research report accurately portrays a well-conceived and elaborate scenario with references to various facets and elements of the market that result in uncompromised growth trajectory.The report draws special references to elements such as product and application segments, regional expanse as well as manufacturing activities, with elaborate cues on dominant trends, persistent challenges as well as untapped market opportunities that systematically lead to uncompromised growth and sustenance in global Wearable Physical Capacity Evaluation System market.This market report is a thoroughly researched analytical review of the current market scenario that directly affect onward growth trajectory of the Wearable Physical Capacity Evaluation System market. The report is a single stop solution aimed at offering actionable insights to adequately influence an unperturbed growth trail in the aforementioned discussed market.

Get Sample Copy of this Report to understand the structure of the complete report: https://www.orbispharmareports.com/sample-request/51912

This systematically compiled research output based on elaborate primary and secondary research practices also shed light on the ongoing implications of COVID-19 that has resulted in lopsided growth in the global Wearable Physical Capacity Evaluation System market through the forecast span.The report is customized section on the back of relentless research and analysis expertise that align with market players objectives to remain profit oriented despite unfavorable market forces that have significantly halted growth and development with pandemic crisis.

Major Company Profiles operating in the Wearable Physical Capacity Evaluation System Market:

HocomaAm CubeMIE Medical ResearchLiteGaitBioMed JenaBTS BioengineeringGaitUpTekscan, Inc.Techno ConceptNovel DEMediTouchExelH/p/cosmosReTiSenseSensor Medica

Read complete report along with TOC @ https://www.orbispharmareports.com/covid-19-impact-on-global-wearable-physical-capacity-evaluation-system-industry-research-report-2020-segmented-by-major-market-players-types-applications-and-countries-forecast-to-2026-2/

Orbis Pharma Reports is a dedicated, best in industry one stop store, offering intensively researched market-oriented information with superlative standards of impartiality and authenticity in order to rightfully influence favorable business decisions across a range of verticals, inclusive of pharmaceutical and healthcare industries. We are highly dependent on our information scavenging abilities and extremely reliant on our intuitive capabilities that lead towards novel opportunity mapping and result in profitable business models and high revenue structures. At Orbis Pharma Reports we categorically offer expert market research-oriented services across a heterogenous range of industrial participants, such as manufacturing companies, corporations, product development companies, who stand in greater need of market specific information.This intricately devised market research protocols encourage ours research experts and analysts to traverse the extra mile towards information procurement, thus enabling us to become requisite research partners and knowledge scavengers to optimally source multidimensional information for superlative market understanding.

By the product type, the market is primarily split into

Posture Analysis SystemGaint Analysis SystemOther

By the application, this report covers the following segments

HospitalClinicRehabilitation CentreOther

TOC Brief: Global Wearable Physical Capacity Evaluation System MarketSection I: Introduction and Market DefinitionSection II: Research MethodologySection III: Executive SummarySection IV: Overview & Highlights on Porters Five Force Analysis, Supply-chain Updates, Threat Analysis of Competitive SubstitutesSection V: Market Dynamics Including DROT OverviewSection VI: Systematic Segmentation of Type, Application and End-UserSection VII: Geographical DiversificationSection VIII: Brief on Premier Competitors, Highlighting M&A, Business Collaborations, Product LaunchSection IX: Key Player Profile

Make an enquiry of this report @ https://www.orbispharmareports.com/enquiry-before-buying/51912

About Us :

At Orbispharma we curate the most relevant news stories, features, analysis and research reports on the important challenges undertaken by the pharmaceutical and related sectors. Our editorial philosophy is to bring you sharp, focused and informed perspective of industries, the end users and application of all upcoming trends into the pharma sector. Orbispharma believes in conversations that can bring a change in one of the most crucial economic sectors in the world. With these conversations we wish our customers to make sound business decisions with right business intelligence.

Contact Us :

See more here:
Wearable Physical Capacity Evaluation System Market 2020 Industry Analysis,Trends and Forecast 2026:Hocoma, Am Cube, MIE Medical Research, LiteGait,...

Germany has as many as 237 billionaires on the basis of the European currency Euro. An old acquaintance is still at the top of the list.

Germanys billionaires made their fortunes by selling hygiene paper, toys, beverages, industry cables, chicken, other food, packaging, campers, software, household appliances, real estate objects and sweets. Since Germany is the land of cars, it is no surprise that the owners of quite a few car parts suppliers made it on the list of the 1,000 richest Germans published by the Welt am Sonntag weekly.

Schwarz is Undisputed Winner

The very richest German national is Dieter Schwarz. It is not the first time he made it to the top of the list, with a fortune of 41.8 billion Euro (49.5 billion U.S. Dollars or 38.3 billion Pounds Sterling). His company, Schwarz-Gruppe, with an annual turnover of 113.3 billion Euro (134.1 billion Dollars or 103.8 billion Pounds), runs ths supermarket chain Lidl and Kaufland, a big box store chains.

About half Schwarz wealth is what the second-richest Germans, the Reimann family is worth. According to the ranking compiled by Welt am Sonntag, the owners of the businesses Coty and Jacobs Douwe Egberts are sitting on 21.45 billion Euro (25.4 billion Dollars or 19.7 billion Pounds).

Porsche and BMW Shareholders

Dieter Schwarz and the Reimann family were able to increase their wealth to some extent since 2019, in spite of or maybe because of the Corona pandemic. Third on the list is Wolfgang Porsche, one of the shareholders at Volkswagen and Porsche, with a fortune of 20 billion Euro flat (23.7 billion Dollars or 18.3 billion Pounds). In Porsches case, nothing much changed since last year.

Susanne Klatten remains Germanys richest woman, with a net worth of 15.1 billion Euro (17.9 billion Dollars or 13.4 billion Pounds). She is a shareholder at both BMW and Altana, a chemicals company. Her brother Stefan Quandt only hit the 9th place on the Welt am Sonntag list. He owns 13.6 billion Euro (16.1 billion Dollars or 12.5 billion Pounds).

Places Five to Ten

Dietmar Hopp, who is on the fifth place, made his fortune with software and bioengineering. Hasso Plattner, on the sixth place, is Hopps partner at the software company SAP. He also deals with art. The seventh and eighth places are being occupied by the families Heister and Albrecht who own the supermarket chain Aldi Sd.

The tenth place goes to businessman Heinz Hermann Thiele who manufactures brakes. At the same time, he is a shareholder of several companies, including Lufthansa. The people mentioned above are only ten out of a total of 237 billionaires in Germany.

Pale in Comparison

While there obviously is a lot of wealth in the Federal Republic of Germany, those on the list still look rather pale next to the richest Americans. Jeff Bezos fortune is about three times larger than Dieter Schwarz. Bill Gates, Mark Zuckerberg, Warren Buffet, Larry Ellison, Steve Ballmer, Elon Musk, Sergey Brin, Alice Walton and several other U.S. citizens are a lot richer than Germanys number one.

The entire Welt am Sonntag list of the 1,000 richest Germans (in German) can be accessed here.

By the way:Thank you for readingThe Berlin Spectator. You can keep on doing so for free, since we do not have any paywalls and we do not intend to introduce any. Thats fine. We are glad you are here.On the other hand, if you likeThe Berlin Spectator, and if you want to support us,you can do so by clickinghere(direct Paypal link). Because of your support, we will worry less. Thank you!

See the original post:
Wealth: Who are the Richest Germans? - The Berlin Spectator

Edward W. Merrill, professor emeritus of chemical engineering, died peacefully at his home on Aug. 6 at the age of 96, surrounded by his children and grandchildren.

A longtime chemical engineer at MIT, Merrill was a founding contributor to the field of biological engineering. He developed the area of biomaterials and over a 66-year career pioneered several fields of bioengineering.

Ed made an indelible mark on each life he touched, professionally and personally. Not only did his research contributions help better the lives of thousands, but his commitment to education and mentorship helped shape a generation of biomedical engineers, says Paula Hammond, the David H. Koch (1962) Professor in Engineering and head of the MIT Department of Chemical Engineering. I experienced it first-hand as a student and a co-teacher; he raised the bar for all of us.

Born in New Bedford, Massachusetts, on Aug. 31, 1923, Merrill grew up in Jamaica Plain and West Roxbury, Massachusetts, and attended the Roxbury Latin School prior to entering Harvard College in 1941 to study the classics. He received a BA in chemistry from Harvard University in 1944 and pursued doctoral studies at MIT under the direction of Herman P. Meissner. Merrill received his ScD in 1947 working on pioneering theories and experimental studies of polymer adhesion. Upon graduation, he was employed by Dewey and Almy (later part of W.R. Grace) and joined MIT as an assistant professor of chemical engineering in 1950. Merrill was appointed the Carbon P. Dubbs Distinguished Professor of Chemical Engineering in 1973, a position he held until 1998. Merrill was a visiting lecturer in chemistry at Harvard University from 1952 to 1958, a consultant at the Peter Bent Brigham Hospital of Boston from 1960 to 1972, a consultant of the Children's Hospital in Boston from 1969 to 1972, and a consultant of the Beth Israel Hospital in Boston from 1969 to 1985. He has also served as chief scientist and consultant in biochemical engineering to Harvard University Health Services from 1984 to 1998.

In the 1950s and '60s, Merrill was the leading scientist in blood rheology. He investigated the effect of the hematocrit, various plasma proteins, and white blood cells on blood viscosity and flow behavior, and he developed appropriate experimental tools for rheological investigations of blood (including the patented GDM [Gilinson-Dauwalter-Merrill] viscometer) under realistic in-vitro conditions. In the 1960s and 1970s, Merrill was a pioneer in the development of the artificial kidney, analysis of its transport characteristics, and optimization of hemodialyzer membranes. In fact, Merrill's pioneering work on artificial kidneys, with Professor Clark Colton PhD 69 and Robert A. Britton ScD 67, led to the development of the first National Institutes of Health guidelines for artificial kidneys in the 1960s. In the 1960s, '70s, and '80s, he pioneered the field of protein/polymer interaction under stagnant and flow conditions and made exceptional contributions in the development of hydrogels as biomaterials, and in ionic or covalent heparinization techniques on polymer surfaces for antithrombogenic materials.

Merrill and Edward Saltzman of Harvard proposed polyethylene oxide (PEO) as a highly biocompatible material in an influential 1979 paper and did significant studies to analyze its stricture and blood response. Merrill's ideas on PEO as a non-thrombogenic biomaterial led to an explosion in the use of PEG- and PEO-decorated biomedical systems. In 1973, Merrill pioneered silicone-based contact lenses that became the basis of the hard, oxygen-permeable contact lens technology. Merrill's work on highly cross-linked polyethylene in the 1990s with William H. Harris led to the new irradiation-cross-linked, high density polyethylene (HDPE) materials used in artificial joints such as knee and hip replacements.

Merrill's contributions in the area of biomedical applications of aerosol engineering were also significant and led to the use of dipalmitoyl-lecithin aerosols for treatment of infants born with hyaline membrane disease (respiratory distress syndrome). Finally, he made significant and sustained contributions to drag reduction phenomena. Merrill was the inventor of more than 40 U.S. patents and about 230 international patents.

Professor Merrill was probably the premier biomedical engineer of the 20th century, says Nicholas Peppas ScD 74, the Cockrell Family Regents Chaired Professor at the University of Texas at Austin and advisee of Merrill, Not only did he develop the fundamentals of the field, and came up with pioneering inventions of blood flow rheometers, non-thrombogenic biomaterials, advanced contact lenses, treatments of the respiratory distress syndrome, and the most successful materials for joint replacements, but he also became a superb educator and mentor who directed and advised hundreds, if not thousands, of biomedically-oriented students of diverse backgrounds and nationalities.

Merrill personally supervised 57 PhD and 62 MS students, and 12 postdocs in his career. About 35 of these became professors in engineering, sciences, or medicine in academic institutions. About 20 of them became entrepreneurs serving as CEOs or other leaders of the chemical, biomedical or pharmaceutical industries. Merrill and eight of his former students or associates were listed in the 2008 AIChE list of "100 Eminent Chemical Engineers of the Modern Era. Fifty-five of his academic descendants are members of the major academies now: 28 are National Academy of Engineering (NAE) members, 19 are members of the National Academy of Medicine (NAM), three are National Academy of Sciences (NAS) members, and five are members of the American Academy of Arts and Sciences (AAAS). Many U.S. and international companies have been founded on his pioneering research ideas by his students and others.

A superb teacher, Merrill taught courses on polymers, biomaterials, transport phenomena, and medical sciences at MIT. His MIT course entitled Chemical Engineering in Medicine and Biology, offered in 1963, was the first such course in the United States. Merrill was a concerned educator and mentor who welcomed in his laboratories numerous scientists from other countries. He had a close association with Paul Rempp of the Macromolecular Center of Strasbourg, France, and in 1991 wrote an impactful book on polymers with him, Polymer Synthesis. At that time, he was also a vice-president of the Boston-Strasbourg Sister City Association and a director of the Alliance Franaise of Boston-Cambridge from 1990-96. He was also consultant to the conservator of the Department of Prints, Drawings, and Photographs at the Museum of Fine Arts, Boston from 1988 to 1998.

Merrill was elected a member of the AAAS, the NAE, the NAM, and the National Academy of Inventors. He received the Founders Award of the American Institute of Chemical Engineers (AIChE) in 2000, the Founders Award of the Society for Biomaterials (SFB) in 2003, and the Pierre Galletti Award from the American Institute of Medical and Biological Engineers in 2010. AIChE had also bestowed upon him the 1982 Alpha Chi Sigma Award and the 1993 Charles M. A. Stine Award. In 1990, the SFB awarded him the Clemson Award. At its centennial celebration in 2008, AIChE recognized him as one of the 100 Eminent Chemical Engineers of the Modern Era.

Merrill married Genevieve "Ginette" de Bidart on Aug. 19, 1948, in Cambridge, Massachusetts. Ginette passed away seven months earlier on Dec. 20, 2019. They are survived by their daughter Anne and son Frank Merrill, and their grandchildren: James, Sasha, and Julia Merrill. Merrill took great pride in his two children and three grandchildren and enjoyed the time he spent with them immensely. He was not simply a father and grandfather, but a mentor and inspiration to all who encountered him. His presence and his wisdom will sorely be missed by all whose lives he touched, and he will be greatly missed by his family. The family has already held private services.

See more here:
Professor Emeritus Edward Merrill, chemical engineer who helped found the field of bioengineering, dies at 96 - MIT News

Miami, Sept. 18, 2020 In an ongoing effort to expand post-graduate opportunities for its students, Miami Dade College (MDC) has established a 4+1 articulation agreement with Florida Atlantic University (FAU) that will allow MDC graduates with a bachelors degree in engineering, data analytics or information systems technology to complete a masters degree at FAU in one year.

MDC has a history of providing excellence in academics, as demonstrated by this partnership with FAU, said Anselm Knights, MDC chairperson of engineering, technology and architecture. This partnership epitomizes the quality we have put into our programs, and we look ahead to a continued collaboration with FAU and further developing the programs we offer.

The agreement assures that students graduating from MDCs School of Engineering and Technology with a Bachelor of Science in electrical and computer engineering technology, upon meeting specific requirements, are eligible for admission into the Master of Science in Electrical Engineering or the Master of Science in Bioengineering programs at FAUs College of Engineering and Computer Science.

Equally, MDC students graduating with a Bachelor of Science in data analytics or Bachelor of Science in information systems technology can complete FAUs Master of Science in information technology and management in one year after completing the program requirements.

This expanded partnership program will enable MDC students to pursue a masters degree in electrical engineering, bioengineering, or information technology and management, said Dr. Stella Batalama, dean of the FAU College of Engineering and Computer Science. We look forward to welcoming these students to our College, and we are excited for them to join the FAU family.

For more information about the articulation agreement visit: http://mdc.tips/fau-ecet

About Miami Dade College

Miami Dade College is the most diverse institution in the nation. There are 174 nations and 69 languages represented in its student body. The colleges eight campuses and outreach centers offer more than 300 distinct degree pathways including associate and baccalaureate degrees, career certificates and apprenticeships. Baccalaureate degree offerings include biological sciences, engineering, data analytics, information systems technology, education, public safety, supervision and management, nursing, physician assistant studies, film, and others. MDC is the recipient of many top national awards including the Aspen Prize. As Democracys College, MDC changes lives through accessible, high quality-teaching and learning experiences. It is the home of the Miami Culinary Institute, the Miami Animation & Gaming International Complex, the Miami Fashion Institute, the Eig-Watson School of Aviation, The Idea Center, the Cybersecurity Center of the Americas, the Cloud Computing Center, the Center for Learning, Innovation and Simulation, the School for Advanced Studies, and the New World School of the Arts, to name a few of its most innovative programs. MDC has been named among the nations Great Colleges to Work For since the programs inception. The College embraces its responsibility to serve as an economic, cultural, and civic leader for the advancement of our diverse global community. Its alumni and employees contribute more than $3 billion annually to the local economy, and MDC graduates occupy top leadership positions in every major industry. MDC is renowned for its rich cultural programming. It is the home of the Miami Book Fair, Miami Film Festival, the National Historic Landmark Miami Freedom Tower, the Tower Theater, Dyer Building, Koubek Center Mansion and Gardens, the Lynn and Louis Wolfson II Florida Moving Image Archives, the Museum of Art and Design, a sculpture park and a large campus art gallery and theater system. MDC has admitted more than 2,000,000 students and counting, since it opened its doors in 1960. For more information, visit http://www.mdc.edu.

About Florida Atlantic University

Florida Atlantic University, established in 1961, officially opened its doors in 1964 as the fifth public university in Florida. Today, the University, with an annual economic impact of $6.3 billion, serves more than 30,000 undergraduate and graduate students at sites throughout its six-county service region in southeast Florida. FAUs world-class teaching and research faculty serves students through 10 colleges: the Dorothy F. Schmidt College of Arts and Letters, the College of Business, the College for Design and Social Inquiry, the College of Education, the College of Engineering and Computer Science, the Graduate College, the Harriet L. Wilkes Honors College, the Charles E. Schmidt College of Medicine, the Christine E. Lynn College of Nursing and the Charles E. Schmidt College of Science. FAU is ranked as a High Research Activity institution by the Carnegie Foundation for the Advancement of Teaching. The University is placing special focus on the rapid development of critical areas that form the basis of its strategic plan: Healthy aging, biotech, coastal and marine issues, neuroscience, regenerative medicine, informatics, lifespan and the environment. These areas provide opportunities for faculty and students to build upon FAUs existing strengths in research and scholarship. For more information, visit fau.edu.

FAU Media-only contact: Gisele Galoustian, media relations director for research, 561-985-4615, ggaloust@fau.edu.

Read this article:
MDC and FAU Announce Articulation Agreement for Master's Degree in Technology and Engineering Programs - The Reporter

Nisin Industry 2020 Global Market research report studies the latest Nisin industry aspects market size, share, trends, Opportunities and Strategies To Boost Growth, business overview, revenue, demand, marketplace expanding, technological innovations, recent development, and Nisin industry scenario during the forecast period (2020-2025).

The major players profiled in this report include:DSM, Dupont, Galactic SA, Handary S.A., Siveele B.V., Zhejiang Silver-Elephant Bioengineering, Shandong Freda Biotechnology, Chihon Biotechnology, Mayasan Biotech, Cayman Chemical

Download Premium Sample of the Report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=194406&RequestType=Sample

Global Nisin Market is valued approximately USD 423.9 million in 2019 and is anticipated to grow with a healthy growth rate of more than 4.5 % over the forecast period 2020-2027. Nisin is a polycyclic antibacterial peptide that is produced by fermentation of food-grade bacteria and used as a food preservative. Nisin increases the shelf life of the food products, thus widely used in processed food, majorly in dairy products, canned food, and meat products. The global Nisin market is facing challenges in the production facilities fully functional due to shortage of staff and resources amidst the COVID-19 (Coronavirus) outbreak. The effective and non-toxic properties than other natural preservatives, nisin acts as a natural preservative with therapeutic benefits, consumer awareness for clean label products are the few factors responsible for growth of the market over the forecast period. Furthermore, the introduction of new products and other strategic alliance by the market players will create a lucrative demand for the market. For instance: In December 2019, Royal DSM acquired Royal CSK (Friesland), a leading food ingredient company in the European region. This acquisition enables both the company to expand their product portfolio and expertise in food & beverage business. However, crucial and sensitive production and use of preservation techniques to discourage demand for nisin are the major factors restraining the growth of global Nisin market during the forecast period.

The regional analysis of global Nisin market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the the increase in consumer preference for synthetic food preservatives. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2020-2027.

Major market player included in this report are:DSMDupontGalactic SAHandary S.A.Siveele B.V.Zhejiang Silver-Elephant BioengineeringShandong Freda BiotechnologyChihon BiotechnologyMayasan BiotechCayman Chemical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:Meat, poultry & seafood productsDairy productsBeveragesBakery & confectionery productsCanned & frozen food productsOthers

By Region:North AmericaU.S.CanadaEuropeUKGermanyFranceSpainItalyROE

Asia PacificChinaIndiaJapanAustralia South KoreaRoAPACLatin AmericaBrazilMexicoRest of the World

Furthermore, years considered for the study are as follows:

Historical year a?? 2017, 2018Base year a?? 2019Forecast period a?? 2020 to 2027

Target Audience of the Global Nisin Market in Market Study:

Key Consulting Companies & AdvisorsLarge, medium-sized, and small enterprisesVenture capitalistsValue-Added Resellers (VARs)Third-party knowledge providersInvestment bankersInvestors

Request Customization of the Report: https://brandessenceresearch.biz/Request/Sample?ResearchPostId=194406&RequestType=Methodology

1 Market Overview1.1 Product Definition and Market Characteristics1.2 Global Nisin Market Size1.3 Market Segmentation1.4 Global Macroeconomic Analysis1.5 SWOT Analysis

3 Associated Industry Assessment3.1 Supply Chain Analysis3.2 Industry Active Participants3.2.1 Suppliers of Raw Materials3.2.2 Key Distributors/Retailers3.3 Alternative Analysis3.4 The Impact of Covid-19 From the Perspective of Industry Chain

4 Market Competitive Landscape4.1 Industry Leading Players4.2 Industry News4.2.1 Key Product Launch News4.2.2 Expansion Plans

5 Analysis of Leading Companies5.1 Company 15.1.1 Company 1 Company Profile5.1.2 Company 1 Business Overview5.1.3 Company 1 Nisin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.1.4 Company 1 Nisin Products Introduction

5.2 Company 25.2.1 Company 2 Company Profile5.2.2 Company 2 Business Overview5.2.3 Company 2 Nisin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.2.4 Company 2 Nisin Products Introduction

5.3 Company 35.3.1 Company 3 Company Profile5.3.2 Company 3 Business Overview5.3.3 Company 3 Nisin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.3.4 Company 3 Nisin Products Introduction

5.4 Company 45.4.1 Company 4 Company Profile5.4.2 Company 4 Business Overview5.4.3 Company 4 Nisin Sales, Revenue, Average Selling Price and Gross Margin (2015-2020)5.4.4 Company 4 Nisin Products Introduction

6 Market Analysis and Forecast, By Product Types6.1 Global Nisin Sales, Revenue and Market Share by Types (2015-2020)6.2 Global Nisin Market Forecast by Types (2020-2026)6.3 Global Nisin Sales, Price and Growth Rate by Types (2015-2020)6.4 Global Nisin Market Revenue and Sales Forecast, by Types (2020-2026)

7 Market Analysis and Forecast, By Applications7.1 Global Nisin Sales, Revenue and Market Share by Applications (2015-2020)7.2 Global Nisin Market Forecast by Applications (2020-2026)7.3 Global Revenue, Sales and Growth Rate by Applications (2015-2020)7.4 Global Nisin Market Revenue and Sales Forecast, by Applications (2020-2026)

8 Market Analysis and Forecast, By Regions8.1 Global Nisin Sales by Regions (2015-2020)8.2 Global Nisin Market Revenue by Regions (2015-2020)8.3 Global Nisin Market Forecast by Regions (2020-2026)Continued.

Read More: https://brandessenceresearch.biz/Chemicals-and-Materials/Nisin-Market-Future-Scope/Summary

About Us: Brandessence Market Research and Consulting Pvt. ltd.

Brandessence market research publishes market research reports & business insights produced by highly qualified and experienced industry analysts. Our research reports are available in a wide range of industry verticals including aviation, food & beverage, healthcare, ICT, Construction, Chemicals and lot more. Brand Essence Market Research report will be best fit for senior executives, business development managers, marketing managers, consultants, CEOs, CIOs, COOs, and Directors, governments, agencies, organizations and Ph.D. Students. We have a delivery center in Pune, India and our sales office is in London.

Contact us at: +44-2038074155 or mail us at[emailprotected]

Blog:https://businessstatsnews.com

Blog:http://www.dailyindustrywatch.com

Blog:https://marketsize.biz

Blog:https://technologyindustrynews.com

Blog:https://marketstatsreport.com

Blog:https://tcbiznews.com/

Top Trending Reports:

https://xherald.com/industry-news/fluoroscopy-equipment-market-size-to-surpass-usd-5-27-billion-by-2025/

https://www.marketwatch.com/press-release/at-33-cagr-polyvinyl-chloride-pvc-market-share-current-trends-and-research-development-report-to-2025-covid-19-impact-analysis-2020-09-17?tesla=y

https://www.marketwatch.com/press-release/at-33-cagr-polyvinyl-chloride-pvc-market-share-current-trends-and-research-development-report-to-2025-covid-19-impact-analysis-2020-09-17?tesla=y

https://www.marketwatch.com/press-release/microcontroller-market-size-share-growth-companies-industry-report-2020-2025-renesas-electronics-f-microchip-technology-nxp-semiconductor-texas-instrument-2020-09-17?tesla=y

https://www.marketwatch.com/press-release/liquid-nitrogen-market-size-growth-opportunity-forecast-and-covid-19-impact-analysis-to-2025-2020-09-17?tesla=y

Follow this link:
Global Nisin Market set to grow with massive rate by 2020 to 2025 - The Daily Chronicle

NIH

One university and six companies have secured contracts from the National Institutes of Health to produce digital health tools in support of coronavirus response efforts.

All seven awardees will aim to develop software, wearable devices or mobile applications intended for contact tracing, health monitoring and test results tracking, NIH said Tuesday.

Phase 1 will focus on demonstrating the feasibility of selected projects and Phase 2 will commence through a contractual option that will include additional funds to support further development and demonstration work.

The agency estimates that the total amount of contracts will reach $22.8M if all participants move forward to the second phase.

The tools these organizations plan to develop could allow us to use containment efforts, like COVID-19 testing, social distancing and quarantine, precisely when and where theyre needed, said Norman Sharpless, director of NIHs National Cancer Institute.

NCI and the National Institute of Biomedical Imaging and Bioengineering, also part of NIH, chose projects from the seven awardees out of almost 200 submissions. These development projects will support a $306M effort, among other NCI and NIBIB pursuits, to address COVID-19, increase testing capacity and conduct serological studies.

The awardees are:

Separately, NIBIB awarded CareEvolution a contract to provide its SAFER-COVID assessment tool that works to fuse data on self-reported symptoms, electronic health records, claims and information from wearable devices in order to help users determine whether they can return to their normal routines.

Read more here:
NIH Taps Six Firms, One University to Create Digital Health Tools - GovConWire

The Global L-Aspartic Acid (CAS 56-84-8) Market Outlook 2018-2023 offers detailed coverage of l-aspartic acid industry and presents main market trends. The market research gives historical and forecast market size, demand, end-use details, price trends, and company shares of the leading l-aspartic acid producers to provide exhaustive coverage of the market for l-aspartic acid. The report segments the market and forecasts its size, by volume and value, on the basis of application, by products, and by geography.

Download Sample of This Strategic Report:https://www.kennethresearch.com/sample-request-10076738

The report has been prepared based on an in-depth market analysis with inputs from key industry participants. The global l-aspartic acid market has been segmented into five major regions, namely, North America (U.S., Canada, and others), Europe (U.K., France, Germany, Russia, and others), Asia-Pacific (China, Japan, India, Australia, and others), South America (Brazil, Argentina, and others), and Middle East & Africa (South Africa, Saudi Arabia, and others). Furthermore, the report also includes an in-depth competitive analysis of the key vendors operating in this market.

Key Regions North America Europe Asia Pacific Middle East & Africa South America

Key Vendors Ajinomoto Co., Inc. Kyowa Hakko Bio Co., Ltd. Koninklijke DSM N.V. Evonik Industries AG Huaibei Xinxing Industrial Co., Ltd. Yantai Hengyuan Bioengineering Co., Ltd. Jiangsu Jiecheng Bioengineering Co., Ltd. Changmao Biochemical Engineering Company Limited Tianjin Bohua Zhonghe Chemical Co., Ltd. request free sample to get a complete list of companies

Key Questions Answered in This Report Analysis of the l-aspartic acid market including revenues, future growth, market outlook Historical data and forecast Regional analysis including growth estimates Analyzes the end user markets including growth estimates. Profiles on l-aspartic acid vendors including products, sales/revenues, SWOT, and market position, recent developments. Market structure, market drivers and restraints.

Request For Full Report:https://www.kennethresearch.com/sample-request-10076738

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

Kenneth Research

Email : [emailprotected]

Phone: +1 313 462 0609

Go here to read the rest:
L-Aspartic Acid (CAS 56-84-8) Market Growth Rate, Opportunities and Market Forecast to 2023 - The Daily Chronicle

FAIRFAX, Va.--(BUSINESS WIRE)--Vibrent Health, a health technology company powering the future of precision health research, today announced it has been awarded a contract worth a potential value of $4.23 million from the National Institutes of Healths (NIH) National Cancer Institute (NCI) and National Institute of Biomedical Imaging and Bioengineering (NIBIB), to develop a large-scale, data-driven approach to fight COVID-19. Vibrent Health will expand and enhance its privacy-protected, cyber secure Digital Health Solutions Platform for Wi-Fi-enabled contact tracing designed to identify outbreaks and advise actions to protect individuals from COVID-19 exposure and to assist society with the return to normalcy.

The current public health crisis is compounded by a lack of scientifically validated technology tools for effective response strategies, said Praduman Jain, Founder and CEO, Vibrent Health. We are proud to be selected by NIH to develop and validate evidence-based contact tracing technology solutions that leverage user-friendly mobile tools and multiple data sources that we believe will have a significant impact on the fight against COVID-19.

The security, stability and depth of Vibrent Healths technology platform enhances contact tracing efforts by collecting data from broad data sources through existing Wi-Fi infrastructures that are pre-installed on most smart devices. The solution utilizes mobile applications, self-reported data, wearable devices and machine learning algorithms.

A critical feature of Vibrents solution will be its ability to differentiate COVID-19 from the Flu, indicating to users if they need to seek medical attention or not, which may alleviate the burden on health care facilities during Flu outbreaks.

Vibrent Healths solution will enable researchers, public health officials and the general public to make appropriate decisions to protect against exposure to COVID-19 and to enable individuals, communities, universities, facilities and event venues to reduce the risk of infection and thus help society to return to work and normal activities. This is especially important for essential workers who are at highest risk of exposure and those with diminished access to healthcare resources.

Digital health technologies built around smartphones and wearable devices will play an essential role in guiding us through the COVID-19 pandemic, said NIBIB Director Bruce J. Tromberg, Ph.D. These platforms can acquire large amounts of data from many different sources spanning from testing technologies to sensors. When this information is analyzed using cutting-edge computational and machine learning methods, everyone will have access to powerful new tools for reducing the risk of infection and returning to normal activities.

In May of this year, NCI and NIBIB invited organizations to submit ideas for digital health technologies that could enhance the public health response to the pandemic. Vibrent Health was selected as one of seven projects from nearly 200 different ideas. This is among the first NIH-awarded contracts to help create a next-generation contact tracing technology solution for public health response that combines the best of science and technology.

With this new contract, Vibrent Health has partnered with several academic organizations that will contribute machine learning for contact tracing, scientific validation and recruitment of medically underserved populations. Partners include Virginia Commonwealth University, Richmond, Virginia, and University of Virginia, Charlottesville, Virginia.

This project has been funded in whole or in part with Federal funds under Contract No. 75N91020C00038, as a component of the Congressionally supported response to COVID-19 from the National Institute of Biomedical Imaging and Bioengineering and the National Cancer Institute, National Institutes of Health, Department of Health and Human Services.

This contract builds on Vibrent Health and the NIHs existing deep collaboration, including the recently announced funding award to continue as the Participant Technology Systems Center (PTSC) of the All of Us Research Program. All of Us is one of historys largest longitudinal research programs, with an aim of partnering with one million or more diverse people living in the United States.

To learn more about how Vibrent Health can accelerate your digital health research, visit: http://www.vibrenthealth.com

About Vibrent Health

Vibrent Healths mission is to accelerate health research to optimize human health through precision technology and digital tools that empower participant engagement, research analytics and research management for researchers, research organizations and research participants. Through its Digital Health Solutions Platform, the company provides a large-scale versatile global platform for health research. The platform provides an infrastructure for data collection from broad sources including genomics, environment, lifestyle, behaviors and electronic health records. Since February 2017 Vibrent Health has served as the Participant Technology Systems Center for the National Institutes of Healths All of Us Research Program, which aims to collect health data from one million or more people to support a wide variety of research studies. To learn more, visit vibrenthealth.com.

Read more here:
Vibrent Health Wins NIH Contract to Develop Powerful New Digital Health Solutions for COVID-19 Contact Tracing to Reduce the Risk of Infection and...

LAWRENCE Red Hot Research will return this fall in a different setting. The series, sponsored by The Commons at the University of Kansas, will take place over Zoom and feature most of the trademark elements of the traditional in-person event as it shifts to a digital channel for connecting scholars to their peers across disciplines.

Red Hot [Remote] Research will continue as a regular Friday event, beginning at 4 p.m. and featuring research from disciplines across the university around core themes. Each session will feature five presenters sharing short talks on an area of focus within their work. The series will continue to open the door for new ways of understanding work through discussion across perspectives.

The first event is scheduled for 4 p.m. Sept. 18 and will focus on Care & Aging. Subsequent sessions are scheduled for Oct. 9 on Rural/Urban, Oct. 23 on Gender & Representation and a special session Oct. 28, hosted in conjunction with a series of events KU has planned to celebrate the 30th anniversary of the Americans with Disabilities Act (ADA).

Additionally, one Red Hot Graduate Research session, an opportunity for graduate students to share their work with colleagues across campus, will be presented remotely Nov. 20.

In keeping with the goals of this series, presenters are asked to consider how other disciplinary perspectives could contribute to their research, the likely next steps for the research and challenges that they face in conducting the research. In turn, audience members are asked to, from their own perspectives, offer insights, questions and ideas.

Check The Commons website for Zoom registration information: https://thecommons.ku.edu/coming-events

Sept. 18: Care & Aging

Oct. 9: Rural / Urban

Emcee: Dave Tell, professor of communication studies and co-director of the Institute for Digital Research in the Humanities

Oct. 23: Gender & Representation

Oct. 28: Disability Studies

Emcee: Dot Nary, assistant research professor, Research & Training Center on Independent Living

Nov. 20: Graduate Research

Emcee: Elise Higgins, doctoral student in women, gender & sexuality studies.

See the article here:
The Commons announces shift to virtual format for Red Hot [Remote] Research in fall 2020 - KU Today

LOS ANGELES, United States: The global Solanesol market is carefully researched in this report, keeping in view important aspects such as market competition, global and regional growth, market segmentation, and market structure. The analysts authoring the report have estimated the size of the global Solanesol market in terms of value and volume with the use of latest research tools and techniques. The report also includes estimations of market shares, revenue, production, consumption, gross margin, CAGR, and other key factors. Readers can expand their knowledge of business strategies, recent developments, and current as well as future progress of leading players of the global Solanesol market.

Get Full PDF Sample Copy of Report: (Including Full TOC, List of Tables & Figures, Chart) https://www.qyresearch.com/sample-form/form/1776151/1535187/global-solanesol-market-report-history-forecast

Besides a dashboard view of the vendor landscape and important company profiles, the competitive analysis offers an encyclopedic examination of the market structure. The company share analysis included in this study helps players to improve their business tactics and compete well against leading market participants. The intensity map prepared by our analysts helps to get a quick view of the presence of several players in the global Solanesol market. The report also provides a footprint matrix of key players of the global Solanesol market. It dives deep into growth strategies, sales footprint, production footprint, and product and application portfolios of prominent names of the industry.

Key Players Mentioned in the Global Solanesol Market Research Report: ExtRx, Zhejiang Yixin Pharmaceutical, Sanming Huajian Bioengineering

Global Solanesol Market by Type: 90% Solanesol, 95% Solanesol

Global Solanesol Market by Application: Coenzyme Q10, Vitamin K2, Other

The report includes a deep segmentation study of the global Solanesol market, where both segments and sub-segments are analyzed in quite some detail. This study will help players to concentrate on high-growth segments and modify their business strategies, if required. The global Solanesol market is segmented on the basis of type, application, and geography. The regional segmentation study offered in the report equips players with useful information and data related to important geographical markets such as North America, China, Europe, India, the U.S., the U.K., and the MEA. Our researchers and analysts use reliable primary and secondary sources for research and data.

Critical Questions Addressed by the Report

Request for customization in Report: https://www.qyresearch.com/customize-request/form/1535187/global-solanesol-market-report-history-forecast

Table of Contents

About Us:

QY Research established in 2007, focus on custom research, management consulting, IPO consulting, industry chain research, data base and seminar services. The company owned a large basic data base (such as National Bureau of statistics database, Customs import and export database, Industry Association Database etc), experts resources (included energy automotive chemical medical ICT consumer goods etc.

More:
Solanesol Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2026| ExtRx, Zhejiang Yixin Pharmaceutical,...

In recent decades, ideas originating with Stanford students and faculty brought technologies that have disrupted industries, revolutionized business and eased communication in our daily lives. But they have also been linked to societal problems such as widening inequality, racial bias and lack of privacy.

Political science professors Margaret Levi and Rob Reich will co-lead the Ethics, Society and Technology (EST) Hub. (Image credit: L.A. Cicero)

As a way of ensuring that technological advances born at Stanford address the full range of ethical and societal implications, the Long-Range Vision launched the Ethics, Society and Technology (EST) Hub, co-led by Margaret Levi and Rob Reich, both professors of political science.

Stanford is home to outstanding ethicists and social scientists but they havent been well integrated into the ways we teach about, or do research related to, technology, said Debra Satz, the Vernon R. and Lysbeth Warren Anderson Dean of theSchool of Humanities and Sciences(H&S). The EST Hub will bring their insights into the conversation with scientists and engineers about such matters as how we might consider the choices we make regarding technologies that have the potential for widespread societal consequences.

The EST Hub will help coordinate and amplify the teaching, research and activities on campus at the intersection of ethics, society and technology.

The wider world knows Stanford for its leading role in technology innovation and disruption, said Reich, who is also director of the McCoy Family Center for Ethics in Society. This initiative is born out of the desire that Stanford also be known for advances in our understanding of the ethical and social dimensions of technology.

Like many initiatives formed through the Long-Range Vision, the EST Hub doesnt create a new permanent entity. Instead, it is expected to have a three to five-year lifespan, with its activities eventually finding homes among Stanfords existing institutes, centers and programs.

Its about culture change in those we touch and incorporating ethics into our practices. We want to jumpstart that activity and then make sure it lasts, said Levi, who is also the Sara Miller McCune Director of the Center for Advanced Study in the Behavioral Sciences.

Reich helped launch a class called CS 182: Computers, Ethics and Public Policy, co-taught by Jeremy Weinstein, professor of political science, and Mehran Sahami, professor of computer science, which explores the intersection of technology, ethics and policy.

In the course CS 181: Computers, Ethics and Public Policy, Stanford students become computer programmers, policymakers and philosophers to examine the ethical and social impacts of technological innovation.

Its the only class I know of where students have to complete technical assignments, policy papers and philosophy papers, Reich said. Hes now exploring similar classes on topics like bioengineering and climate science. We want to take this idea beyond computer science, he said.

The EST Hub, in collaboration with Stanford Institute for Human-Centered Artificial Intelligence (HAI) and the computer science department, has also begun working with a postdoctoral fellow on a program called Embedded EthiCS, which will embed ethics modules into core computer science courses. We want to make it inescapable that technology majors get exposed to questions of ethics and policy, Reich said.

In addition to the ongoing curricular work, The EST Hub recently gave out six grants for people developing classes that integrate ethics, society and technology. These include classes focused on race in STEM, the risks and opportunities digital technologies present in civil society, an online version of an existing course on ethical urban data analysis, integrating diverse cultural perspectives in ethics training for global technologies, the ethics of using digital ecosystems for training performance artists and role-playing workshops for engineering courses.

Levi and Reich said they hope these courses and others that follow will ensure all STEM students at Stanford encounter opportunities to consider the social and ethical implications of technology.

We want to get to a point where we have dozens of classes in which students are seeing ethics as part of what their education is all about, Levi said.

In addition to supporting ethics in STEM education, The EST Hub is hoping to inspire faculty and students to focus on ethical questions in their research and in their lives. They recently awarded grants to both students and faculty to further those goals.

Levi said she was excited about the level of enthusiasm and creativity students showed in their proposals. They really have some ideas and energy for how to bring these practices into their lives and into the ways people are interacting with each other, she said.

The funded student proposals include two focused on the arts. One creates a magazine focused on the intersection of society and technology and another supports a film project that explores how broader issues of power, culture and our ethical priorities influence current developments of artificial intelligence. The students also proposed a CS fellowship focused on social good and a student group that reflects on and advocates for a more thoughtful approach to thedevelopment and role of technology. They are also exploring how Stanfords tech ecosystem has changed over the last decade, addressing the gaps that remain in student understanding of free speech across interdisciplinary fields and creating acollaboration between faculty and students dedicated to mitigating existential risks.

Funded faculty teams span the Schools of Medicine, Engineering and Humanities and Sciences. They include a project exploring whether digital tools could slow the spread of misinformation and the effects of artificial intelligence-mediated conversation. Another grant supports bioengineering fellows, and one creates an ethical review board for technology research. That board has already reviewed grants funded by HAI, and will review another round of grants in the fall. They expect to publish findings and best practices with the idea that it could inform the groups future work at Stanford and inspire related boards at other universities.

Although the EST Hub launched prior to the novel coronavirus, the international pandemic has revealed to everyone the ways technology is intertwined with individual and social well-being. To explore those implications, The EST Hub funded rapid response research into the societal effects of technology involved in COVID-19 efforts, including research into Zoom fatigue, digital theater, crisis education and photography to chronicle the pandemic across the socioeconomic spectrum.

Levi and Reich said that by embedding ethics in STEM and technology education, and creating new opportunities for students and faculty to engage in ethics in their lives and in their research, theyll create a culture that will endure when the EST Hub dissolves.

The hub integrates whats going on across the university, Levi said. If at the end our students, researchers and faculty practice differently in how they conduct research and lead their lives that would be a success.

Read more from the original source:
Ethics, Society and Technology Hub embeds ethics in teaching and research | Stanford News - Stanford University News

Two Imperial College London projects have won a total of 11.5 million to transform healthcare technologies by 2050.

The UKRI EPSRC Transformative Healthcare Technologies for 2050 funding aims to foster the development of revolutionary new technological approaches to transform care and treatments in the NHS by 2050.

A new Imperial-led project will monitor the brain in a way never achieved before.

The project team, led by Professor Dario Farina at the Department of Bioengineering, will develop a new technology, known as Non-Invasive Single Neuron Electrical Monitoring (NISNEM), with the aim of helping scientists better understand neurological diseases like stroke and Parkinsons.

The researchers hope the technology will enable new neurotechnology-based treatments that are non-invasive and more effective than current ones.

Current approaches to monitoring the brain, like using surgical implants, are invasive. However, NISNEM technology uses electrical signals recorded on the skin surface from extremely high-density electrode probes to create images of the brain, which AI algorithms then scan to find traces of individual neuron activities. These decoded neural activities could reveal signs of neurological impairments like stroke and Parkinsons, and help drive brain-computer interfaces for assistance and therapy.

Stroke affects more than more than 100,000 people per year in the UK, and occurs when the supply of blood to the brain is reduced or blocked. It most commonly arises in the cerebral artery, which directly affects the motor cortex, and can cause substantial impairments in the motor abilities of patients affecting walking and speech.

Parkinsons disease affects 1 in 500 people, causing parts of the brain to become progressively damaged over many years. It develops when dopamine-producing cells in the brain stop working properly and are lost over time. This causes a lack of dopamine in the brain, which is important for movement and speech, and causes tremor, slowness of movement, and muscle stiffness.

Stroke and Parkinsons are only two examples of the impairments targeted by the new NISNEM technology. The researchers hope the new technology will detect brain abnormalities to help early diagnosis of these progressive diseases as well as developing non-invasive treatments.

Professor Farina said: The current inability to access single neuron activity in the brain not only limits our ability to understand and diagnose neurological conditions, but also prevents the broad adoption of neurotechnologies in healthcare. We hope our technology, funded by the EPSRC grant, will provide a breakthrough in understanding, diagnosing, and treating increasingly prevalent neurological conditions, such as stroke, Parkinsons disease, and Alzheimers.

A University of Bristol-led project involving Imperials Professor Molly Stevens aims to develop artificial robotic muscular assistance to help restore strength in people who have lost muscle capability. This could include patients who have suffered a stroke or are living with degenerative diseases such as sarcopenia and muscular dystrophy.

Using these highly targeted robotics could help overcome the limitations of current wearable assistive technologies in regenerative medicine. Often, these technologies can be bulky and uncomfortable to wear, and can require two people to put on and take off. Users can also find the movements too slow.

Through using robots to boost the performance of such technologies, the project, called emPOWER, could provide life-changing benefits for sufferers by restoring their confidence, independence and quality of life - all while reducing the cost to the NHS.

Co-investigator Professor Stevens of the Department of Materials said: Loss of strength and muscle wastage is currently an unenviable part of getting older and has a significant impact on health and quality of life. emPOWER will explore how artificial muscles could radically transform treatment options in the future and effectively turn back the body clock.

emPOWER is led by Professor Jonathan Rossiter at Bristol, in partnership with Imperial, UCL and the NIHR Devices for Dignity MedTech Co-operative, hosted by Sheffield Teaching Hospitals Foundation Trust.

Science minister Amanda Solloway announced the funding as part of her keynote speech at London Tech Week 2020.

She said: The pioneering projects we are backing today will help modernise healthcare, improving all of our lives now and into the future. This announcement is part of our ambitious R&D Roadmap and underlines our commitment to back our incredible scientists and researchers and invest in ground-breaking research to keep the UK ahead in cutting-edge discoveries.

View post:
AI-based brain monitoring and robotic muscle projects win 11.5m EPSRC boost | Imperial News - Imperial College London

The globalProcessed Food & Beverage Preservatives Marketis carefully researched in the report while largely concentrating on top players and their business tactics, geographical expansion, market segments, competitive landscape, manufacturing, and pricing and cost structures. Each section of the research study is specially prepared to explore key aspects of the global Processed Food & Beverage Preservatives market. For instance, the market dynamics section digs deep into the drivers, restraints, trends, and opportunities of the global Processed Food & Beverage Preservatives market. With qualitative and quantitative analysis, we help you with thorough and comprehensive research on the global Processed Food & Beverage Preservatives market. We have also focused on SWOT, PESTLE, and Porters Five Forces analyses of the global Processed Food & Beverage Preservatives market.

Leading players of the global Processed Food & Beverage Preservatives market are analyzed taking into account their market share, recent developments, new product launches, partnerships, mergers or acquisitions, and markets served. We also provide an exhaustive analysis of their product portfolios to explore the products and applications they concentrate on when operating in the global Processed Food & Beverage Preservatives market. Furthermore, the report offers two separate market forecasts one for the production side and another for the consumption side of the global Processed Food & Beverage Preservatives market. It also provides useful recommendations for new as well as established players of the global Processed Food & Beverage Preservatives market.

Request sample copy of this report:https://www.reporthive.com/request_sample/2294008

Major Players:

Celanese CorporationKoninklijke DSM N.V.E.I.du Pont de Nemours and CompanyKerry Group PlcGalactic SAHawkins Watts LimitedInnophos Holdings IncKemin Industries, IncCargill, IncorporatedAkzo Nobel N.V.Albemarle CorporationNaturalin Bio-Resources Co., LtdShandong Kunda Biotechnology Co., LtdShanghai Ruidian Trading Development Co.Ecochem Group Co., LtdNingbo Pangs Chem Intl Co., Ltd.Zhejiang Silver Elephant Bioengineering Co., Ltd.Shandong Tong Tai Wei Run Chemical Co., LtdLaiwu Taihe Biochemistry Co., LtdSEEBIO BIOTECH (SHANGHAI) CO.,LTD

Segmentation by Product:

NaturalBenzoatesNitritesSulfiteSorbates/Propionates

Segmentation by Application:

BakeryConfectioneryMeat, Poultry & Sea FoodDairyBeverages/Snack Food/Frozen Food/Fats and Oils

Regions and Countries:U.S, Canada, France, Germany, UK, Italy, Rest of Europe, India, China, Japan, Singapore, South Korea, Australia, Rest of APAC, Brazil, Mexico, Argentina, Rest of LATAM, Saudi Arabia, South Africa, UAE.

Report Objectives

Table of Contents

Report Overview:It includes major players of the global Processed Food & Beverage Preservatives market covered in the research study, research scope, and Market segments by type, market segments by application, years considered for the research study, and objectives of the report.

Global Growth Trends:This section focuses on industry trends where market drivers and top market trends are shed light upon. It also provides growth rates of key producers operating in the global Processed Food & Beverage Preservatives market. Furthermore, it offers production and capacity analysis where marketing pricing trends, capacity, production, and production value of the global Processed Food & Beverage Preservatives market are discussed.

Market Share by Manufacturers:Here, the report provides details about revenue by manufacturers, production and capacity by manufacturers, price by manufacturers, expansion plans, mergers and acquisitions, and products, market entry dates, distribution, and market areas of key manufacturers.

Market Size by Type:This section concentrates on product type segments where production value market share, price, and production market share by product type are discussed.

Market Size by Application:Besides an overview of the global Processed Food & Beverage Preservatives market by application, it gives a study on the consumption in the global Processed Food & Beverage Preservatives market by application.

Production by Region:Here, the production value growth rate, production growth rate, import and export, and key players of each regional market are provided.

Consumption by Region:This section provides information on the consumption in each regional market studied in the report. The consumption is discussed on the basis of country, application, and product type.

Company Profiles:Almost all leading players of the global Processed Food & Beverage Preservatives market are profiled in this section. The analysts have provided information about their recent developments in the global Processed Food & Beverage Preservatives market, products, revenue, production, business, and company.

Market Forecast by Production:The production and production value forecasts included in this section are for the global Processed Food & Beverage Preservatives market as well as for key regional markets.

Market Forecast by Consumption:The consumption and consumption value forecasts included in this section are for the global Processed Food & Beverage Preservatives market as well as for key regional markets.

Value Chain and Sales Analysis:It deeply analyzes customers, distributors, sales channels, and value chain of the global Processed Food & Beverage Preservatives market.

Key Findings:This section gives a quick look at important findings of the research study.

Request for Customization:https://www.reporthive.com/request_customization/2294008

About us:

Our research base consists of a wide spectrum of premium market research reports. Apart from comprehensive syndicated research reports, our in-house team of research analysts leverages excellent research capabilities to deliver highly customized tailor-made reports. The market entry strategies presented in our reports has helped organizations of all sizes to generate profits by making timely business decisions. The research information including market size, sales, revenue, and competitive analysis offered, is the product of our excellence in the market research domain.

Link:
COVID-19 Impact ON Processed Food & Beverage Preservatives Market Size and CAGR by Regional Forecast by 2020-2026 | Celanese Corporation,...

Campus and Community

ByKristen Bailey | October 16, 2020 Atlanta, GA

Click image to enlarge

The Petit Institute for Bioengineering and Bioscience will host a conversation next week with two campus leaders on the topic of Covid-19 Is a Health Disparity. The event will feature Kaye Husbands Fealing, dean and Ivan Allen Jr. Chair in the Ivan Allen College of Liberal Arts, with an opening presentation by Manu Platt, associate professor in the Wallace H. Coulter Department of Biomedical Engineering.

The conversation will take place Monday, Oct. 19, from 1 to 2 p.m. via Microsoft Teams, with a maximum capacity of 250 attendees, limited to those logged in with a Georgia Tech email address. Attendees will have the chance to ask questions, and a recording will be made available on thePetit websitefollowing the event.

In addition to the many research angles of Covid-19 including therapeutics, diagnoses, co-morbidities, public health, public policy, and healthcare systems this session will highlight the health disparities associated with Covid-19, providing an additional perspective into this public health crisis.

The discussion has been planned and organized by a committee for diversity, equity, and inclusion within the Petit Institute. The group was formed in September following a June town hall and a collective desire within the community to take action following national race-related tragedies.

The goal of our committeeis to create a safer, more inclusive, and more highly prosperous environment for our historically underrepresented minority faculty, trainees, and staff, said Ed Botchwey, committee chair and associate professor in the Coulter Department. We hope to maintain a focus on anti-racism action within our Institute.

In support of this goal, the group began hosting town halls within the Petit community on ways to think about systemic racism across disciplines.

We must confront the routines, biases, and contradictions that preserve the status quo, Botchwey said. This town hall is a fresh call to antiracist action in the bioengineering and bioscience community. Im looking forward to our conversation as we look for ways in which all of our members can answer the call.

Other committee members include:

View original post here:
Petit Institute to Host Race and Racism Event on Covid-19 - Georgia Tech News Center

Laboratory Compressors And Pumps Market research report is the new statistical data source added by A2Z Market Research.

Laboratory Compressors And Pumps Market is growing at a High CAGR during the forecast period 2020-2026. The increasing interest of the individuals in this industry is that the major reason for the expansion of this market.

Laboratory Compressors And Pumps Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing top players and the upcoming competitors. Business strategies of the key players and the new entering market industries are studied in detail. Well explained SWOT analysis, revenue share and contact information are shared in this report analysis.

Get the PDF Sample Copy (Including FULL TOC, Graphs and Tables) of this report @:

https://www.a2zmarketresearch.com/sample?reportId=322397

Note In order to provide more accurate market forecast, all our reports will be updated before delivery by considering the impact of COVID-19.

Top Key Players Profiled in this report are:

Hangzhou Tailin Bioengineering Equipments, JUN-AIR International A/S, Gardner Denver, Heidolph, Coaire, General europe vacuum, Hirschmann

The key questions answered in this report:

Various factors are responsible for the markets growth trajectory, which are studied at length in the report. In addition, the report lists down the restraints that are posing threat to the global Laboratory Compressors And Pumps market. It also gauges the bargaining power of suppliers and buyers, threat from new entrants and product substitute, and the degree of competition prevailing in the market. The influence of the latest government guidelines is also analyzed in detail in the report. It studies the Laboratory Compressors And Pumps markets trajectory between forecast periods.

Get up to 30% Discount on this Premium Report @:

https://www.a2zmarketresearch.com/discount?reportId=322397

Global Laboratory Compressors And Pumps Market Segmentation:

Market Segmentation by Type:

Vacuum pumpsLaboratory peristaltic pumpsCompressorsVacuum systems

Market Segmentation by Application:

Lab Instruments

Regions Covered in the Global Laboratory Compressors And Pumps Market Report 2020:The Middle East and Africa(GCC Countries and Egypt)North America(the United States, Mexico, and Canada)South America(Brazil etc.)Europe(Turkey, Germany, Russia UK, Italy, France, etc.)Asia-Pacific(Vietnam, China, Malaysia, Japan, Philippines, Korea, Thailand, India, Indonesia, and Australia)

The cost analysis of the Global Laboratory Compressors And Pumps Market has been performed while keeping in view manufacturing expenses, labor cost, and raw materials and their market concentration rate, suppliers, and price trend. Other factors such as Supply chain, downstream buyers, and sourcing strategy have been assessed to provide a complete and in-depth view of the market. Buyers of the report will also be exposed to a study on market positioning with factors such as target client, brand strategy, and price strategy taken into consideration.

The report provides insights on the following pointers:

Table of Contents

Global Laboratory Compressors And Pumps Market Research Report 2020 2026

Chapter 1 Laboratory Compressors And Pumps Market Overview

Chapter 2 Global Economic Impact on Industry

Chapter 3 Global Market Competition by Manufacturers

Chapter 4 Global Production, Revenue (Value) by Region

Chapter 5 Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6 Global Production, Revenue (Value), Price Trend by Type

Chapter 7 Global Market Analysis by Application

Chapter 8 Manufacturing Cost Analysis

Chapter 9 Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10 Marketing Strategy Analysis, Distributors/Traders

Chapter 11 Market Effect Factors Analysis

Chapter 12 Global Laboratory Compressors And Pumps Market Forecast

Buy Exclusive Report @:

https://www.a2zmarketresearch.com/buy?reportId=322397

If you have any special requirements, please let us know and we will offer you the report as you want.

About A2Z Market Research:

The A2Z Market Research library provides syndication reports from market researchers around the world. Ready-to-buy syndication Market research studies will help you find the most relevant business intelligence.

Our Research Analyst Provides business insights and market research reports for large and small businesses.

The company helps clients build business policies and grow in that market area. A2Z Market Research is not only interested in industry reports dealing with telecommunications, healthcare, pharmaceuticals, financial services, energy, technology, real estate, logistics, F & B, media, etc. but also your company data, country profiles, trends, information and analysis on the sector of your interest.

Contact Us:

Roger Smith

1887 WHITNEY MESA DR HENDERSON, NV 89014

[emailprotected]

+1 775 237 4147

Laboratory Compressors And Pumps, Laboratory Compressors And Pumps market, Laboratory Compressors And Pumps Market 2020, Laboratory Compressors And Pumps Market insights, Laboratory Compressors And Pumps market research, Laboratory Compressors And Pumps market report, Laboratory Compressors And Pumps Market Research report, Laboratory Compressors And Pumps Market research study, Laboratory Compressors And Pumps Industry, Laboratory Compressors And Pumps Market comprehensive report, Laboratory Compressors And Pumps Market opportunities, Laboratory Compressors And Pumps market analysis, Laboratory Compressors And Pumps market forecast, Laboratory Compressors And Pumps market strategy, Laboratory Compressors And Pumps market growth, Laboratory Compressors And Pumps Market Analysis in Developed Countries, Laboratory Compressors And Pumps Market by Application, Laboratory Compressors And Pumps Market by Type, Laboratory Compressors And Pumps Market Development, Laboratory Compressors And Pumps Market Evolving Opportunities With Top Industry Experts, Laboratory Compressors And Pumps Market Forecast to 2025, Laboratory Compressors And Pumps Market Future Innovation, Laboratory Compressors And Pumps Market Future Trends, Laboratory Compressors And Pumps Market Google News, Laboratory Compressors And Pumps Market Growing Demand and Growth Opportunity, Laboratory Compressors And Pumps Market in Asia, Laboratory Compressors And Pumps Market in Australia, Laboratory Compressors And Pumps Market in Europe, Laboratory Compressors And Pumps Market in France, Laboratory Compressors And Pumps Market in Germany, Laboratory Compressors And Pumps Market in Key Countries, Laboratory Compressors And Pumps Market in United Kingdom, Laboratory Compressors And Pumps Market is Booming, Laboratory Compressors And Pumps Market is Emerging Industry in Developing Countries, Laboratory Compressors And Pumps Market Latest Report, Laboratory Compressors And Pumps Market, Laboratory Compressors And Pumps Market Rising Trends, Laboratory Compressors And Pumps Market Size in United States, Laboratory Compressors And Pumps Market SWOT Analysis, Laboratory Compressors And Pumps Market Updates, Laboratory Compressors And Pumps Market in United States, Laboratory Compressors And Pumps Market in Canada, Laboratory Compressors And Pumps Market in Israel, Laboratory Compressors And Pumps Market in Korea, Laboratory Compressors And Pumps Market in Japan, Laboratory Compressors And Pumps Market Forecast to 2026, Laboratory Compressors And Pumps Market Forecast to 2027, Laboratory Compressors And Pumps Market comprehensive analysis, Hangzhou Tailin Bioengineering Equipments, JUN-AIR International A/S, Gardner Denver, Heidolph, Coaire, General europe vacuum, Hirschmann

Read this article:
Comprehensive Report on Laboratory Compressors And Pumps Market 2020 | Trends, Growth Demand, Opportunities & Forecast To 2026 | Hangzhou Tailin...